Bill Maughan
Stock Analyst at Clear Street
(0.93)
# 3,329
Out of 5,165 analysts
23
Total ratings
31.25%
Success rate
-11.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bill Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNTH Dianthus Therapeutics | Maintains: Buy | $100 → $130 | $78.90 | +64.77% | 2 | Mar 10, 2026 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $21 → $28 | $8.68 | +222.58% | 1 | Mar 3, 2026 | |
| KRRO Korro Bio | Upgrades: Buy | $10 → $18 | $12.31 | +46.22% | 2 | Feb 19, 2026 | |
| CRBU Caribou Biosciences | Initiates: Buy | $13 | $1.97 | +559.90% | 1 | Feb 2, 2026 | |
| CLLS Cellectis | Initiates: Buy | $9 | $3.45 | +160.87% | 1 | Dec 23, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $22 → $47 | $12.46 | +277.21% | 2 | Dec 9, 2025 | |
| ANNX Annexon | Initiates: Buy | $17 | $5.61 | +203.03% | 1 | Dec 2, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $190 | $256.33 | -25.88% | 1 | Jul 1, 2025 | |
| CRSP CRISPR Therapeutics AG | Downgrades: Hold | $45 | $50.09 | -10.16% | 1 | Jun 27, 2025 | |
| NKTX Nkarta | Maintains: Buy | $16 → $15 | $2.32 | +546.55% | 2 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $9 | $1.13 | +696.46% | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $63 → $67 | $30.73 | +118.03% | 3 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $91 → $106 | $53.93 | +96.55% | 3 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $2.29 | +948.03% | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $5.07 | +1,083.43% | 1 | Feb 21, 2024 |
Dianthus Therapeutics
Mar 10, 2026
Maintains: Buy
Price Target: $100 → $130
Current: $78.90
Upside: +64.77%
Ocular Therapeutix
Mar 3, 2026
Maintains: Buy
Price Target: $21 → $28
Current: $8.68
Upside: +222.58%
Korro Bio
Feb 19, 2026
Upgrades: Buy
Price Target: $10 → $18
Current: $12.31
Upside: +46.22%
Caribou Biosciences
Feb 2, 2026
Initiates: Buy
Price Target: $13
Current: $1.97
Upside: +559.90%
Cellectis
Dec 23, 2025
Initiates: Buy
Price Target: $9
Current: $3.45
Upside: +160.87%
Wave Life Sciences
Dec 9, 2025
Maintains: Buy
Price Target: $22 → $47
Current: $12.46
Upside: +277.21%
Annexon
Dec 2, 2025
Initiates: Buy
Price Target: $17
Current: $5.61
Upside: +203.03%
Krystal Biotech
Jul 1, 2025
Initiates: Buy
Price Target: $190
Current: $256.33
Upside: -25.88%
CRISPR Therapeutics AG
Jun 27, 2025
Downgrades: Hold
Price Target: $45
Current: $50.09
Upside: -10.16%
Nkarta
May 10, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.32
Upside: +546.55%
May 10, 2024
Maintains: Buy
Price Target: $11 → $9
Current: $1.13
Upside: +696.46%
May 9, 2024
Maintains: Hold
Price Target: $63 → $67
Current: $30.73
Upside: +118.03%
May 3, 2024
Maintains: Hold
Price Target: $91 → $106
Current: $53.93
Upside: +96.55%
Mar 15, 2024
Maintains: Buy
Price Target: $22 → $24
Current: $2.29
Upside: +948.03%
Feb 21, 2024
Reiterates: Buy
Price Target: $60
Current: $5.07
Upside: +1,083.43%